Hymon® Colorectal Cancer Screening Kit will show in 2023 MEDICA, booths 17D40-4
- Innovation and Cooperation using the Nobel Prize in PCR Technology
- The only Chinese company cited by US FDA commissioner
HymonBio’s innovative Blood DNA Colorectal Cancer Screening Kit covers 3 gene methylation and 1 gene mutation, combining unique ECS Magnetic Bead Extraction Technology and Molecular Lock Amplification Technology (MoLock) to greatly improve extraction efficiency of low-concentration small fragment cell-free nucleic acid, and greatly improve sensitivity and specificity. Clinical studies have shown detection sensitivity reaching 96% and specificity of 93%. The test uses non-invasive blood samples for convenience and higher compliance rates.
Technical Advantages
- Multidimensional full coverage, Detects 3 gene methylation and 1 gene mutation
- Unique ECS Magnetic Bead Extraction Technology, Uses different sized beads to improve extraction efficiency by up to 90%
- Patented MoLock Technology, Antibodies “locks in” wild type genes to prevent their amplification, erasing interference and noise by up to 99%
- Convenient sampling, only 5ml Peripheral blood samples used
Post time: Sep-15-2023